Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday [Yahoo! Finance]
BioCryst Pharmaceuticals, Inc. (BCRX)
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
biocryst.gcs-web.com/investor-relations
Company Research
Source: Yahoo! Finance
But BioCryst Pharmaceuticals (NASDAQ: BCRX) and its investors had a really good day, as the company delivered a first quarter that convincingly beat analyst estimates. The market rewarded this performance by pushing BioCryst's share price more than 18% higher on the day. A double beat in the opening quarter of 2024 BioCryst showed some solid growth numbers in that earnings report. For the quarter, it earned just under $93 million in total revenue, which was nearly 35% higher on a year-over-year basis. In terms of debits from the profit and loss statement, the pharmaceutical company managed to shave its all-important research and development expenses by almost $2 million thanks to discontinuations and out-licensing activities with several pipeline drugs. As for the bottom line, BioCryst did a good job of narrowing its net loss. On both a generally accepted accounting principles ( GAAP ) and non-GAAP (adjusted) basis, this was a much slimmer $35 million ($0.17) per share compare
Show less
Read more
Impact Snapshot
Event Time:
BCRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BCRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BCRX alerts
High impacting BioCryst Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
BCRX
News
- Fortrea Appoints Machelle Sanders to Board of Directors [Yahoo! Finance]Yahoo! Finance
- BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical ImmunologyGlobeNewswire
- Pint Pharma announces ORLADEYO approval in Mexico for HAE prevention [Yahoo! Finance]Yahoo! Finance
- ORLADEYO® (berotralstat) Approved in MexicoGlobeNewswire
- Analysts Are Updating Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Estimates After Its First-Quarter Results [Yahoo! Finance]Yahoo! Finance
BCRX
Earnings
- 5/6/24 - Beat
BCRX
Sec Filings
- 5/15/24 - Form 4
- 5/15/24 - Form 4
- 5/15/24 - Form 4
- BCRX's page on the SEC website